SHR-4602 for Injection in Subjects With HER2-expressing or -Mutated Unresectable or Metastatic Solid Tumors
PHASE2This is an open-label, randomized, multi-center phase II study to evaluate ...
Location
Fudan University Shanghai Cancer Center
A Trial of SHR-4602 Infusion in Patients With SHR-4602 in Subjects With HER2-expressing or HER2-mutated Locally Advanced or Metastatic Solid Tumors
PHASE1To evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics...
Location
Scientia Clinical Research Limited
A Phase II Study of SHR-4602 as Montherapy or in Combination With Other Anti-tumor Therapies in Advanced Solid Tumors
PHASE2The study is being conducted to evaluate the safety, tolerability, pharmaco...
Location
Beijing Cancer Hospital